Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03238703
Title Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Recruitment Withdrawn
Gender female
Phase FDA approved
Variant Requirements Yes
Sponsors Fred Hutchinson Cancer Research Center
Indications

breast carcinoma

Therapies

Tamoxifen

Exemestane

Toremifene

Anastrozole

Letrozole

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST